mewburn-logo-white mewburn-logo
  • About us
    • About us
    • Working with our Munich Office
    • Our AI Strategy & Action Plan
    • Who we work with
    • How we work with our clients
    • The Mewburn Ellis culture
    • Community giving
    • Inclusion & diversity
      • Inclusion & diversity
      • Gender Pay Gap
      • Women in IP
    • Sustainability
    • Join Mewburn Ellis
      • Join Mewburn Ellis
      • Vacancies
    • Graduate training programme
    • Business partners
      • Business partners
      • Code of conduct
      • Diversity policy
      • Environmental policy
  • Our People
    • Our People
    • View All People
    • Our Leadership Team
  • About you
    • Who we work with
    • I'm an attorney/law firm
    • I'm a university/R&D
    • I'm a corporate
    • I'm an SME
    • I'm a start up/spin out
  • Which service?
    • Services
    • I want to patent an invention
      • I want to patent an invention
      • Chemistry Patents
      • Engineering Patents
      • Life Sciences Patents
      • Patent Disputes
      • Patent Renewals
      • European Patent Validations
      • Pharma Patent Extensions & Regulatory Exclusivity
    • I want to protect a brand
      • I want to protect a brand
      • Register a trade mark
      • Trade mark disputes
      • Trade mark renewals
      • I want to change a domain name
    • I want to protect my design
      • Register a Design
      • Design Renewals
    • I need help with contentious proceedings
      • Contentious proceedings
      • post grant proceedings
      • oppositions or appeals
      • IP litigation or disputes
      • The Unified Patent Court
    • I need some commercial advice
    • I need to validate my European patent
    • I want to renew my ip rights
  • Spotlight on
    • Health
      • Advanced therapeutics
      • Animal health
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future food
      • Medical technologies
      • Microbiome
      • Pharmaceuticals
      • Plants
      • Precision medicine
      • Speciality pharma
    • Technology
      • Artificial Intelligence (AI)
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future mobility
      • Green & sustainable technologies
      • Medical technologies
      • New Nuclear Technologies
      • Quantum Technology
      • Software
      • Space Technology
    • Industry
      • 2d materials
      • Automotive
      • Energy storage
      • Green tech
      • Marine & ocean engineering
      • Medical devices
      • Polymers
      • Pharmaceuticals
      • Plants
      • Speciality pharma
      • Synthetic biology
    • Intellectual property
      • Brexit
      • Green ip
      • Ip litigation
      • Oppositions - chemistry & materials
      • Oppositions - engineering & ICT
      • Oppositions - life sciences
      • UPC
      • Women in ip
  • Knowledge hub
    • Law & practice library
    • News, insights & features
    • Special reports
    • Films
    • Events and Webinars
  • Contact us
    • Offices
    • 8 Bishopsgate
    • Residencies
  • en
  • zh-hans
  • germany
  • ja
  • ko
  • About us
    • About us
    • Working with our Munich Office
    • Our AI Strategy & Action Plan
    • Who we work with
    • How we work with our clients
    • The Mewburn Ellis culture
    • Community giving
    • Inclusion & diversity
      • Inclusion & diversity
      • Gender Pay Gap
      • Women in IP
    • Sustainability
    • Join Mewburn Ellis
      • Join Mewburn Ellis
      • Vacancies
    • Graduate training programme
    • Business partners
      • Business partners
      • Code of conduct
      • Diversity policy
      • Environmental policy
  • Our People
    • Our People
    • View All People
    • Our Leadership Team
  • About you
    • Who we work with
    • I'm an attorney/law firm
    • I'm a university/R&D
    • I'm a corporate
    • I'm an SME
    • I'm a start up/spin out
  • Which service?
    • Services
    • I want to patent an invention
      • I want to patent an invention
      • Chemistry Patents
      • Engineering Patents
      • Life Sciences Patents
      • Patent Disputes
      • Patent Renewals
      • European Patent Validations
      • Pharma Patent Extensions & Regulatory Exclusivity
    • I want to protect a brand
      • I want to protect a brand
      • Register a trade mark
      • Trade mark disputes
      • Trade mark renewals
      • I want to change a domain name
    • I want to protect my design
      • Register a Design
      • Design Renewals
    • I need help with contentious proceedings
      • Contentious proceedings
      • post grant proceedings
      • oppositions or appeals
      • IP litigation or disputes
      • The Unified Patent Court
    • I need some commercial advice
    • I need to validate my European patent
    • I want to renew my ip rights
  • Spotlight on
    • Health
      • Advanced therapeutics
      • Animal health
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future food
      • Medical technologies
      • Microbiome
      • Pharmaceuticals
      • Plants
      • Precision medicine
      • Speciality pharma
    • Technology
      • Artificial Intelligence (AI)
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future mobility
      • Green & sustainable technologies
      • Medical technologies
      • New Nuclear Technologies
      • Quantum Technology
      • Software
      • Space Technology
    • Industry
      • 2d materials
      • Automotive
      • Energy storage
      • Green tech
      • Marine & ocean engineering
      • Medical devices
      • Polymers
      • Pharmaceuticals
      • Plants
      • Speciality pharma
      • Synthetic biology
    • Intellectual property
      • Brexit
      • Green ip
      • Ip litigation
      • Oppositions - chemistry & materials
      • Oppositions - engineering & ICT
      • Oppositions - life sciences
      • UPC
      • Women in ip
  • Knowledge hub
    • Law & practice library
    • News, insights & features
    • Special reports
    • Films
    • Events and Webinars
  • Contact us
    • Offices
    • 8 Bishopsgate
    • Residencies
  • All topics
  • Forward
  • Artificial Intelligence
  • Battery Technologies
  • Bioinformatics
  • Brexit
  • Chemistry
  • Commercial Advice
  • Community
  • COVID-19
  • Designs
  • Energy Storage
  • Engineering
  • EU Unitary Patent / Unified Patent Court
  • FemTech
  • Future Food Tech
  • Future Mobility
  • Graphene & 2D Materials
  • Green Tech
  • ICT
  • Life Sciences
  • Litigation
  • Marine & Ocean Engineering
  • Materials
  • MedTech
  • Microbiome
  • Nature based materials
  • Nuclear
  • On-Demand
  • Oppositions
  • Patents
  • Pharmaceuticals
  • Plants
  • Polymers
  • Polymer recycling
  • Precision Medicine
  • Quantum Computing
  • SME
  • Software
  • Space Tech
  • Synthetic Biology
  • Trade Marks
AI speaking the language of life will produce life-saving gene therapies (not memes)!
Isabelle Murray - May 7, 2025

AI speaking the language of life will produce life-saving gene therapies (not memes)!

Expression constructs are among the most widely used tools in modern biological research. These ...

A new sequencing technology extends the NGS revolution
Jennifer Hoang - April 28, 2025

A new sequencing technology extends the NGS revolution

Completed in 2003, the first human genome sequence took 13 years to finish and cost approximately ...

How AI is impacting IP strategy in Advanced Materials
Matthew Smith - April 17, 2025

How AI is impacting IP strategy in Advanced Materials

The use of Artificial Intelligence (AI) and Machine Learning (ML) in chemical exploration is ...

Unlocking immortality: the innovations driving human longevity
Sean Constable - February 10, 2025

Unlocking immortality: the innovations driving human longevity

Science has made great strides in dramatically increasing life expectancy. In the 1900s, the ...

Alchemab: the art of AI antibody discovery
Camille Terfve - October 29, 2024

Alchemab: the art of AI antibody discovery

Alchemab’s artificial intelligence platform enables the identification of antibodies for some of ...

King’s Speech: AI implications for IP
Emma Graham - August 14, 2024

King’s Speech: AI implications for IP

Featuring in The Patent Lawyer Magazine, Emma Graham explores what the King's Speech said about AI, ...

An emotional day - The Court of Appeal reverses the High Court’s earlier judgment
Alex Burns - July 19, 2024

An emotional day - The Court of Appeal reverses the High Court’s earlier judgment

Today, the Court of Appeal handed down its hotly-anticipated judgment in the Emotional Perception ...

Living with artificial intelligence: can the law cope?
Emma Kennaugh-Gallacher - June 28, 2024

Living with artificial intelligence: can the law cope?

As part of our Thought Leaders series, we explore the copyright issues arising from AI-generated ...

How data changed our understanding and care of breast cancer
Camille Terfve - May 31, 2024

How data changed our understanding and care of breast cancer

Breast cancer does not only affect women, but it mostly affects them1. Breast cancer is the most ...

The brilliant dawn of AI drug discovery
Camille Terfve - April 26, 2024

The brilliant dawn of AI drug discovery

Computer simulations are solving challenges previously thought uncrackable.

The link between the microbiome and chronic liver disorders
Eliot Ward - February 29, 2024

The link between the microbiome and chronic liver disorders

Guts UK is the charity for the digestive system. It funds scientific research such as Nicholas ...

AI bias in healthcare
Joe Egelstaff - January 16, 2024

AI bias in healthcare

AI tools are increasingly being used in healthcare settings, with applications ranging from ...

Meet The Team: Sean Jauss, Partner, Solicitor, Litigator, Head of Legal Services
Sean Jauss - September 13, 2023

Meet The Team: Sean Jauss, Partner, Solicitor, Litigator, Head of Legal Services

As part of our 'meet the team' series, we talk to head of legal and dispute resolution, Sean Jauss, ...

Gene sequencing accelerates with custom hardware
Alex Burns - May 5, 2023

Gene sequencing accelerates with custom hardware

The cost to sequence a genome continues to drop exponentially. Over the past 20 years, the cost to ...

Motion capture and AI in healthcare
Callum Anderson - April 4, 2023

Motion capture and AI in healthcare

When most of us hear the term motion capture, we tend to think of special effects in films and ...

AI and Tech innovation stands out in a slow year for pharma deals
Christopher Casley - February 9, 2023

AI and Tech innovation stands out in a slow year for pharma deals

Last year saw a drop in the number and value of deals performed in the biotech and pharma sector ...

Meet the team: Emma Graham, Partner and Patent Attorney in the Engineering team, London
Emma Graham - February 2, 2023

Meet the team: Emma Graham, Partner and Patent Attorney in the Engineering team, London

As part of our 'meet the team' series, we talk to Emma Graham about her love of patent drafting, ...

Meet the team: Camille Terfve, Partner and Patent Attorney in the Life Sciences team, Cambridge
Camille Terfve - January 31, 2023

Meet the team: Camille Terfve, Partner and Patent Attorney in the Life Sciences team, Cambridge

As part of our 'meet the team' series, we talk to Camille Terfve about her journey to becoming a ...

Meet the team: Christopher Casley, Partner and Patent Attorney in the Life Sciences team, Bristol
Christopher Casley - January 20, 2023

Meet the team: Christopher Casley, Partner and Patent Attorney in the Life Sciences team, Bristol

As part of our 'meet the team' series, we talk to Christopher Casley about why he enjoys life as a ...

Bioinformatics at the UK IPO – what does the new Guidance mean for applicants?
Camille Terfve - October 17, 2022

Bioinformatics at the UK IPO – what does the new Guidance mean for applicants?

As recently publicised, the UK IPO recently issued new guidance relating to examining patent ...

The smart healthcare revolution – what does it mean for patent attorneys?
Alex Burns - November 22, 2021

The smart healthcare revolution – what does it mean for patent attorneys?

In 2020 the EPO published a report on the global trends in patent applications for “Fourth ...

From academia to patents – a career path to becoming a patent attorney
Camille Terfve - November 16, 2021

From academia to patents – a career path to becoming a patent attorney

Camille Terfve spoke to EMBL Careers about what it takes to become a patent attorney. This was ...

Digital therapeutics: the rise of digital health technologies during the Covid-19 pandemic
Camille Terfve - November 12, 2021

Digital therapeutics: the rise of digital health technologies during the Covid-19 pandemic

There is no denying that the Covid-19 pandemic has reshaped many aspects of our lives. Those lucky ...

A snapshot: Patent Landscape in Bioinformatics and Digital Health
Christopher Casley - October 21, 2021

A snapshot: Patent Landscape in Bioinformatics and Digital Health

In this Forward: On Demand vlog, Christopher Casley gives us an overview of our special report on ...

Patent Landscape in Bioinformatics and Digital Health Special Report
Camille Terfve - August 5, 2021

Patent Landscape in Bioinformatics and Digital Health Special Report

Our new Special Report, Patent Landscape in Bioinformatics and Digital Health: a data driven ...

Materials informatics: a data-based approach to materials discovery
Nathan Zhang - May 20, 2021

Materials informatics: a data-based approach to materials discovery

Research into new materials with desirable properties has been one of the most long-standing ...

How to patent your digital health apps – 5 key considerations
Alex Burns - January 26, 2021

How to patent your digital health apps – 5 key considerations

As the technical capabilities of smartphones continue to rise at an exponential rate, so too do the ...

Deep learning cracks the protein folding problem?
Camille Terfve - December 3, 2020

Deep learning cracks the protein folding problem?

Deep learning has just made a new headline grabbing achievement: DeepMind’s latest AI-powered ...

Genomics medicine has already proved its potential: the (success) story of non-invasive prenatal testing
Camille Terfve - September 24, 2020

Genomics medicine has already proved its potential: the (success) story of non-invasive prenatal testing

We have previously discussed the tremendous progress made towards the adoption of genomics medicine ...

Can software be therapeutic?
Camille Terfve - July 14, 2020

Can software be therapeutic?

The simple answer is: yes. Thanks for reading this post, stay tuned for more answers to your ...

String theory: how bundling IP rights strengthens bioinformatics products
Sean Jauss - July 14, 2020

String theory: how bundling IP rights strengthens bioinformatics products

As part of our Thought Leaders series, Mewburn Ellis Partner Sean Jauss explores how bundling IP ...

Protecting IP in bioinformatics and digital health: tips and tricks to tackle the “moving target problem”
Camille Terfve - July 6, 2020

Protecting IP in bioinformatics and digital health: tips and tricks to tackle the “moving target problem”

As previously discussed, data driven approaches have revolutionised research and R&D in the ...

A Guide to Patenting Bioinformatics Inventions at the EPO: what is technical and why does it matter?
Camille Terfve - June 23, 2020

A Guide to Patenting Bioinformatics Inventions at the EPO: what is technical and why does it matter?

Many inventions in the field of bioinformatics (a term that we will use herein to encompass ...

Have we entered the era of the DIY superhuman?
Camille Terfve - June 3, 2020

Have we entered the era of the DIY superhuman?

Self-improvement products are everywhere around us, on our bookshelves and supermarket shelves ...

Coronavirus (COVID-19), big data and silver linings
Camille Terfve - April 23, 2020

Coronavirus (COVID-19), big data and silver linings

There is no denying that the COVID-19 pandemic will have tremendous practical and economic impact ...

What use is computational biology during the coronavirus (COVID-19) pandemic?
Camille Terfve - April 6, 2020

What use is computational biology during the coronavirus (COVID-19) pandemic?

There is one obvious way in which computational biology is showing its strengths in the current ...

Bioinformatics - science's big secret
Camille Terfve - March 18, 2020

Bioinformatics - science's big secret

Now deeply woven into the fabric of biological research, bioinformatics has become the secret sauce ...

Bioinformatics, data and healthcare: Benefits and challenges of data-driven medicine
Camille Terfve - March 9, 2020

Bioinformatics, data and healthcare: Benefits and challenges of data-driven medicine

Algorithms (sometimes collectively referred to as ‘digital health’) are changing the way that ...

Genomics and Biodata in 2020: the future is here!
Camille Terfve - February 14, 2020

Genomics and Biodata in 2020: the future is here!

I have been working in the field of bioinformatics/computational biology for 10 years now and have ...

Genomics and Biodata in 2020: so much data, so little time?
Camille Terfve - February 7, 2020

Genomics and Biodata in 2020: so much data, so little time?

Having attended the Festival of Genomics & Biodata 2020 conference last week, it is clear that ...

Advancements of genetic testing
Katherine Collins - January 29, 2020

Advancements of genetic testing

The sequencing of the first human genome in 2003 was a major breakthrough in genomics. While this ...

Simulations in bioinformatics and the G1/19 referral
Camille Terfve - January 23, 2020

Simulations in bioinformatics and the G1/19 referral

What’s all this about? Claims directed to methods of simulation or modelling of a system or process ...

AI, deep learning and image analysis in bioinformatics
Camille Terfve - January 2, 2020

AI, deep learning and image analysis in bioinformatics

Putting “AI” in the title of your paper, or indeed in the name of your company, seems to have ...

Bioinformatics: biological and medical sciences in the age of big data
Camille Terfve - December 16, 2019

Bioinformatics: biological and medical sciences in the age of big data

What is bioinformatics? Bioinformatics is a term which we will use as an umbrella to encompass work ...

Bioinformatics is everywhere!
Camille Terfve - December 16, 2019

Bioinformatics is everywhere!

As discussed in a previous post, most types of biological or medical data that can be collected ...

EPO Bioinformatics Roadshow
Camille Terfve - October 30, 2019

EPO Bioinformatics Roadshow

There is still a relatively prevalent view in the field of bioinformatics and medical informatics ...

Patentable subject matter in bioinformatics - USPTO’s January 2019 guidance
Camille Terfve - August 15, 2019

Patentable subject matter in bioinformatics - USPTO’s January 2019 guidance

In this article, Paul Liu and Ashley Barton from Duane Morris LLP provided some interesting ...

Pioneers of precision medicine
Frances Salisbury - April 15, 2019

Pioneers of precision medicine

Breakthroughs in healthcare promise a future in which the individual sits at the centre of medical ...

Bioinformatics Inventions: Patenting challenges at the interface of computer and life sciences
Frances Salisbury - February 27, 2019

Bioinformatics Inventions: Patenting challenges at the interface of computer and life sciences

We are entering an age of precision medicine, with patients receiving tailored treatments, selected ...

More

  • Slavery Act
  • Legal Notices
  • Terms and Conditions
  • Privacy
  • Forward Community Programme
  • Client Login
  • Join Mewburn Ellis

Follow us

Subscribe

Sign up to Forward: news, insights and features from Mewburn Ellis

Contact

  • mail@mewburn.com
  • London:

    +44 (0)20 7776 5300
  • Bristol:

    +44 (0)117 945 1234
  • Cambridge:

    +44 (0)1223 420383
  • Manchester:

    +44 (0)161 2477 722
  • Munich:

    +49 (0)89 244 459800

Copyright © 2025 Mewburn Ellis. All rights reserved. Terms and Conditions & Online Privacy